Dr Christopher Leo Cheang Han

Clinical Interest:

Interventional nephrology, glomerulonephritis, chronic kidney disease, haemodialysis and peritoneal dialysis.


Dr Christopher Leo graduated from the Auckland University School of Medicine in 2002. He worked for several years in New Zealand prior to moving to Singapore in 2005. After completing Internal Medicine and Nephrology Specialist training in Tan Tock Seng Hospital, he was awarded the Healthcare Manpower Development Plan Fellowship in endovascular intervention for vascular dialysis access in Sydney, Australia. He is a Fellow of the Royal College of Physicians of Edinburgh and the Academia of Medicine Singapore as well as an Adjunct Assistant Professor with Yong Loo Lin School of Medicine, National University of Singapore.

Prior to joining the Raffles Hospital, Dr Leo was a Consultant in the National University Hospital and Director of the Nephrology Senior Residency Program and Interventional Nephrology Services. His clinical proficiency encompasses caring for patients on haemodialysis and peritoneal dialysis, as well as patients with glomerulonephritis and other acute or chronic kidney diseases. He is also skilled in performing percutaneous renal biopsies in addition to various dialysis access procedures, including tunneled dialysis catheters, peritoneal dialysis catheters and endovascular interventions for arteriovenous fistula/graft.

Dr Leo has published several scientific papers in international peer-reviewed journals in dialysis access, general nephrology and dialysis related topics. He is a guest speaker and conducts workshops in local and international conferences to share his expertise. He was awarded the National University Health System (NUHS) Heroes Educator Award 2020 in recognition of his contributions to post-graduate training in Nephrology. As a Renal Chapter Board Member of the Academia of Medicine and Executive Committee Member of the Society of Dialysis Access Specialists, he is passionate about enhancing the delivery of care to patients with renal diseases in the community at large. His commitment to improving patient outcomes led to his team being presented with a Merit Award for a quality improvement initiative that significantly reduced hospital acquired Methicillin Resistant Staphylococcus Aureus catheter related blood stream infections.


MB ChB (New Zealand), FAMS (S’pore), FRCPEd (UK)